Corcept Therapeutics Incorporated (CORT) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | 30.7% | 25.2% | 22.0% | 20.7% | 13.1% | 6.23% | ||
| Changes by years, y/y, % | +1pp | -6pp | -3pp | -1pp | -8pp | -15.3% | |||
Corcept Therapeutics Incorporated. Net margin, %
Corcept Therapeutics Incorporated. Net margin, changes, pp
Corcept Therapeutics Incorporated (CORT) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net margin, % | ? | 13.1% | 18.1% | 9.47% | 12.0% | -18.9% | 6.23% | |
| Changes by years, y/y, % | -6pp | -4pp | -16pp | -5pp | -32pp | |||
| Changes by quarters, q/q, % | -4pp | +5pp | -9pp | +3pp | -31pp | |||